porcin
epidem
diarrhea
viru
pedv
member
genu
alphacoronaviru
within
famili
coronavirida
genom
rna
grna
contain
six
known
open
read
frame
encod
replicas
polyprotein
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
accessori
protein
glycoprotein
mediat
receptor
bind
membran
fusion
viru
entri
harbor
major
viral
neutral
epitop
pedv
classic
strain
genogroup
emerg
unit
kingdom
caus
endem
outbreak
mani
european
asian
countri
highli
virul
pedv
strain
emerg
china
virus
sinc
spread
north
america
europ
asian
countri
caus
epidem
outbreak
result
massiv
mortal
neonat
piglet
pedv
first
detect
us
swine
caus
death
million
pig
within
year
lead
billion
econom
loss
prevent
control
deadli
diseas
us
depart
agricultur
condit
licens
two
pedv
vaccin
one
viral
vectorbas
subunit
vaccin
harrisvaccin
inc
acquir
merck
co
inactiv
vaccin
zoeti
inc
nevertheless
efficaci
vaccin
remain
question
togeth
knowledg
vaccin
swine
enter
virus
rotaviru
transmiss
gastroenter
viru
tgev
oral
immun
sow
live
attenu
vaccin
lav
promis
approach
protect
newborn
piglet
highli
virul
pedv
pedv
lav
base
classic
strain
appli
asian
countri
efficaci
emerg
highli
virul
strain
minim
probabl
due
antigen
differ
protein
strain
develop
pedv
lav
research
group
previous
appli
tradit
method
attenu
via
serial
passag
virul
isol
vero
cell
although
lav
candid
attenu
suffici
pig
usual
fail
consist
induc
adequ
protect
immun
challeng
virul
strain
one
potenti
reason
multipl
mutat
accumul
gene
vero
celladapt
pedv
mutat
may
alter
antigen
protein
impair
viral
immunogen
vivo
lead
decreas
efficaci
therefor
better
strategi
pedv
lav
maintain
critic
epitop
protein
conserv
wildtyp
virus
retain
optim
immunogen
major
concern
lav
safeti
issu
caus
point
mutat
recombin
field
therefor
pedv
lav
harbor
ration
introduc
mutat
multipl
locat
viral
genom
reduc
potenti
revers
virul
vaccin
candid
gener
use
infecti
cdna
clone
virul
pedv
strain
similar
coronavirus
cov
pedv
replicas
polyprotein
process
nonstructur
protein
nsp
respons
viral
replic
transcript
translat
etc
end
viral
genom
rna
subgenom
mrna
sgmrna
contain
cap
structur
methyl
guanosin
nucleosid
cap
methyl
group
posit
cap
first
nucleotid
cap
structur
critic
effect
translat
viral
protein
evas
host
innat
immun
methyl
two
site
cap
catalyz
three
nsp
methyltransferas
mtase
domain
cov
contain
catalyt
tetrad
amino
acid
residu
k
k
e
directli
respons
enzymat
activ
inactiv
demonstr
effect
approach
ration
design
lav
candid
cov
sinc
viral
protein
highli
conserv
among
cov
recombin
virus
carri
mutat
usual
viabl
document
introduct
substitut
sever
acut
respiratori
syndrom
cov
sarscov
middl
east
respiratori
syndrom
cov
merscov
equival
substitut
mous
hepat
viru
mhv
attenu
cov
mice
subsequ
studi
also
demonstr
inactiv
exonucleas
domain
attenu
sarscov
mice
increas
genet
stabil
moreov
primari
infect
recombin
sarscov
fulli
protect
mice
lethal
challeng
virul
viru
suggest
cov
abolish
could
univers
lav
platform
addit
mutat
studi
appli
knowledg
pedv
gener
evalu
lav
platform
use
virul
pedv
infecti
cdna
clone
backbon
pedv
mutant
inactiv
gener
partial
complet
replac
catalyt
tetrad
achiev
higher
level
attenu
reduc
potenti
revers
inactiv
endocytosi
signal
cytoplasm
tail
protein
gener
demonstr
previous
inactiv
endocytosi
signal
partial
attenu
virul
neonat
piglet
without
alter
major
neutral
epitop
lack
signal
also
caus
protein
transport
cell
surfac
potenti
lead
improv
recognit
pedv
mutant
host
immun
system
present
studi
evalu
virul
immunogen
genet
stabil
mutant
neonat
gnotobiot
gn
pig
also
character
abil
trigger
interferon
ifn
respons
vitro
structur
biochem
studi
sarscov
reveal
replac
residu
catalyt
tetrad
alanin
significantli
inactiv
activ
first
model
structur
pedv
found
put
catalyt
tetrad
highli
homolog
counterpart
sarscov
fig
c
next
introduc
singl
alanin
substitut
quadrupl
alanin
substitut
design
mutant
catalyt
tetrad
gener
two
recombin
pedv
mutant
fig
final
third
mutant
construct
inactiv
kdke
endocytosi
signal
protein
fig
three
mutant
rescu
vero
cell
supernat
contain
rescu
virus
harvest
passag
singl
clone
mutant
purifi
plaqu
assay
complet
genom
sequenc
pedv
mutant
verifi
sanger
sequenc
character
phenotyp
recombin
pedv
vero
cell
growth
curv
fig
b
mutant
replic
similarli
virul
includ
similar
peak
infecti
titer
fig
mutant
also
form
plaqu
similar
size
fig
contrast
replic
significantli
lower
peak
titer
p
demonstr
previous
sya
mutat
gene
enhanc
abil
mutant
icya
induc
cellcel
fusion
produc
larg
plaqu
thu
mutant
produc
larger
plaqu
replic
effici
earli
time
point
mutant
also
document
sarscov
merscov
mutant
sensit
respons
cell
cultur
wildtyp
virus
compar
replic
recombin
pedv
vero
cell
pretreat
differ
concentr
fig
pretreat
inhibit
replic
dosedepend
manner
although
mutant
produc
significantli
lower
titer
progeni
virus
virul
mutant
sensit
higher
concentr
mutant
sinc
mutat
locat
transcript
regulatori
sequenc
tr
fig
subgenom
level
icya
vero
cell
one
unit
lower
cell
fig
recent
studi
highlight
fact
type
iii
ifn
includ
play
signific
role
inhibit
pedv
infect
vitro
also
report
mhv
mutant
induc
stronger
product
wildtyp
viru
murin
macrophag
evalu
whether
pedv
mutant
trigger
enhanc
type
type
iii
ifn
respons
infect
cell
infect
swine
intestin
epitheli
cell
line
ipecdq
uvinactiv
pedv
mutant
multipl
infect
moi
cell
mock
treat
transfect
poli
neg
posit
control
growth
curv
analysi
show
mutant
replic
significantli
lower
titer
virus
h
postinocul
hpi
fig
quantifi
mrna
swine
infect
cell
fig
f
compar
virul
icya
mutant
induc
significantli
higher
mrna
level
ifn
hpi
uvinactiv
stimul
ifn
respons
next
perform
luciferas
assay
examin
whether
infect
mutant
pedv
activ
promot
hpi
fig
h
ifn
promot
activ
mocktreat
cell
howev
mutant
activ
promot
induc
significantli
stronger
luciferas
activ
ipecdq
cell
p
collect
data
suggest
pedv
mutant
trigger
stronger
type
type
iii
ifn
product
infect
cell
virul
pedv
compar
singl
mutant
mutant
replic
less
effect
sensit
respons
vitro
investig
pathogenesi
immunogen
neonat
gn
piglet
first
day
postinocul
dpi
clinic
sign
mortal
observ
pig
mockinocul
group
tabl
eight
piglet
sever
diarrhea
die
within
dpi
piglet
sever
diarrhea
one
piglet
die
dpi
comparison
one
piglet
sever
diarrhea
day
pig
die
fig
piglet
significantli
lower
delay
peak
infecti
pedv
shed
titer
pig
versu
pfuml
p
tabl
signific
differ
observ
amount
infecti
pedv
rectal
swab
fig
intestin
content
fig
pig
time
point
level
sera
collect
two
pig
euthan
dpi
differ
significantli
among
three
group
fig
pedv
n
protein
visual
epitheli
cell
jejunum
ileum
pedvinocul
piglet
use
immunohistochemistri
ihc
stain
fig
sever
villou
atrophi
infect
pig
quantifi
measur
ratio
villu
height
crypt
depth
vhcd
ratio
villu
two
mutant
induc
significantli
milder
villou
atrophi
jejunum
ileum
mutant
induc
significantli
milder
villou
atrophi
ileum
mutant
fig
p
collect
data
suggest
inactiv
catalyt
tetrad
kdke
protein
significantli
attenu
highli
virul
pedv
neonat
piglet
addit
inactiv
endocytosi
signal
protein
reduc
virul
dpi
surviv
pig
challeng
highli
virul
high
dose
pfupig
tabl
mortal
observ
group
wherea
two
mockchalleng
pig
die
day
postchalleng
dpc
fig
dpc
pig
diarrhea
one
pig
mild
diarrhea
day
howev
mockchalleng
pig
develop
sever
diarrhea
day
tabl
fig
infecti
pedv
detect
rectal
swab
sampl
pig
group
one
sampl
one
pig
group
pedv
posit
day
low
infecti
titer
pfuml
howev
mockchalleng
pig
shed
high
titer
infecti
pedv
fece
dpc
fig
fecal
pedv
rnashed
profil
trend
rna
shed
group
chang
significantli
contrast
mockchalleng
pig
shed
significantli
higher
titer
infecti
pedv
dpc
viral
rna
dpc
group
p
also
determin
viral
neutral
vn
antibodi
titer
sera
collect
dpc
dpc
dpc
fig
primari
infect
two
pedv
mutant
piglet
elicit
vn
antibodi
challeng
challeng
significantli
boost
titer
dpc
significantli
higher
mockchalleng
pig
p
summari
infect
piglet
induc
protect
respect
diarrhea
follow
subsequ
challeng
virul
revers
virul
lav
repres
safeti
concern
use
livestock
mutant
harbor
nucleotid
substitut
genom
induc
protect
neonat
pig
evalu
genet
stabil
introduc
mutat
serial
passag
viru
pig
three
time
fig
viral
genom
intestin
content
third
passag
verifi
sanger
sequenc
sequenc
alter
found
nine
introduc
mutat
fig
viru
acquir
one
synonym
mutat
two
synonym
mutat
one
nonsynonym
mutat
subunit
fig
sequenc
cytoplasm
tail
region
rectal
swab
sampl
n
n
pig
collect
dpi
find
revers
introduc
mutat
data
shown
due
low
pedv
rna
titer
rang
n
gene
copiesml
rectal
swab
sampl
abl
amplifi
suffici
amount
complet
genom
sequenc
mutant
collect
data
indic
introduc
mutat
catalyt
tetrad
pedv
cytoplasm
tail
region
stabl
vivo
emerg
reemerg
enter
cov
swine
includ
pedv
porcin
deltacoronaviru
pdcov
swine
acut
diarrhea
syndrom
sad
cov
rais
concern
econom
impact
global
pork
industri
cov
caus
clinic
similar
gastroenter
induc
crossneutr
pig
necessari
develop
effect
safe
lav
individu
cov
protein
cov
highli
conserv
among
cov
repres
suitabl
mutagenesi
target
purpos
current
studi
use
pedv
exampl
valid
concept
evalu
virul
recombin
pedv
bear
inactiv
viral
newborn
gn
pig
character
protect
efficaci
pig
challeng
highli
virul
pedv
combin
inactiv
activ
endocytosi
signal
protein
show
mutant
attenu
induc
better
protect
virulentpedv
challeng
also
confirm
introduc
mutat
genom
stabl
passag
mutant
viru
gn
pig
three
time
current
pedv
strain
circul
among
pig
differ
countri
two
subtyp
pedv
cocircul
unit
state
highli
virul
origin
us
pedv
strain
eg
clinic
milder
sindel
pedv
strain
eg
previou
studi
demonstr
live
sindel
strain
induc
partial
crossprotect
challeng
origin
us
pedv
although
two
subtyp
pedv
induc
similar
level
vn
antibodi
serum
vn
antibodi
crossreact
sera
collect
studi
also
crossneutr
sindel
strain
level
vero
cell
data
shown
pig
experi
need
examin
whether
origin
us
pedvbas
mutant
induc
suffici
protect
challeng
heterolog
sindel
pedv
strain
howev
origin
us
pedv
strain
main
target
pedv
lav
due
high
virul
preval
field
catalyt
tetrad
kdke
highli
conserv
coronavirida
also
viral
famili
show
consist
attenu
phenotyp
similarli
engin
cov
flavivirus
paramyxoviru
pedv
mutant
without
activ
attenu
neonat
gn
piglet
becam
vulner
innat
immun
respons
fig
mutant
harbor
four
alanin
substitut
catalyt
tetrad
differ
previous
report
mhv
sarscov
merscov
contain
one
amino
acid
mutat
shown
replac
residu
alanin
almost
complet
abolish
activ
escherichia
coliexpress
sarscov
vitro
studi
demonstr
first
time
cov
lack
kdke
residu
still
viabl
vitro
vivo
design
also
improv
safeti
pedv
lav
candid
activ
restor
four
alanin
substitut
revert
kdke
pedv
mutant
evalu
pig
specul
singl
mutant
might
virul
mutant
similar
observ
mutant
sarscov
merscov
unlik
sarscov
merscov
mutant
replic
equival
wild
type
mutant
replic
lower
titer
fig
b
gener
smaller
plaqu
fig
parent
viru
vero
cell
one
potenti
reason
kdke
residu
may
unknown
function
viral
replic
also
possibl
pedv
mutant
may
still
retain
margin
activ
wherea
mutant
may
complet
lost
enzymat
activ
substanti
evid
support
point
obtain
quantif
percentag
viral
rna
mutant
use
radioactivelabel
approach
less
effici
replic
vero
cell
may
drawback
largescal
product
pedv
lav
issu
overcom
use
engin
cell
line
support
effect
replic
mutant
report
replic
mhv
mutant
also
poor
wildtyp
macrophag
enhanc
interferoninduc
protein
tetratricopeptid
repeat
ifit
knockout
macrophag
altern
stabl
express
wildtyp
cell
line
may
compens
inactiv
catalyt
tetrad
function
mutant
restor
viru
propag
vitro
although
cell
line
may
facilit
revers
mutant
vitro
similar
infect
enter
rna
virus
pedv
infect
elicit
type
type
iii
ifn
trigger
innat
immun
respons
pig
secret
variou
immun
epitheli
cell
known
induc
antivir
effect
system
act
clear
enter
viral
pathogen
restrict
replic
epitheli
cell
contrast
mainli
produc
epitheli
cell
activ
antivir
respons
mucos
site
howev
sever
studi
report
pedvinfect
epitheli
cell
line
express
significantli
increas
amount
type
type
iii
ifn
earli
stage
infect
usual
within
h
probabl
due
inhibit
multipl
viral
protein
far
determin
least
pedv
protein
suppress
ifn
product
includ
e
n
instanc
inactiv
endoribonucleas
pedv
reduc
ifn
antagon
result
enhanc
induct
type
type
iii
ifn
vitro
viral
attenu
vivo
present
studi
also
observ
similar
result
pedv
mutant
inactiv
mutant
trigger
earlier
ifn
respons
ipecdq
cell
probabl
due
viral
rna
trigger
sensor
molecul
melanoma
differentiationassoci
protein
inocul
induc
higher
level
sera
pig
euthan
dpi
fig
like
due
much
robust
replic
virul
two
mutant
vivo
could
determin
local
ifn
respons
intestin
tissu
due
pig
euthan
earli
time
point
eg
within
hpi
base
studi
vero
celladapt
pedv
lav
level
host
immun
respons
correl
effici
viral
replic
intestin
tendenc
induc
stronger
local
ifn
respons
earli
stage
infect
pedv
mutant
may
contribut
overal
immunogen
although
virus
replic
less
robustli
vivo
investig
infect
pedv
mutant
pig
porcin
enteroid
cultur
may
discov
detail
mechan
compar
doubl
mutant
display
higher
level
attenu
piglet
induc
better
protect
diarrhea
postchalleng
high
dose
highli
virul
pedv
doubl
mutant
may
induc
improv
immun
respons
pig
potenti
due
combin
effect
icya
mutant
mutat
cytoplasm
tail
protein
inactiv
endocytosi
signal
yevf
also
disrupt
tr
sgmrna
nucleotid
fig
result
decreas
synthesi
infect
cell
sinc
pedv
protein
ifn
antagonist
icya
mutant
also
induc
higher
type
type
iii
ifn
respons
ipecdq
cell
fig
moreov
inactiv
endocytosi
signal
enhanc
format
syncytia
may
facilit
spread
mutant
cell
earli
stage
infect
observ
mutant
replic
slightli
higher
titer
mutant
dpi
piglet
tabl
fig
lack
endocytosi
signal
increas
amount
protein
present
surfac
infect
enterocyt
contribut
better
cell
activ
futur
studi
cellular
immun
respons
mutant
pig
warrant
increas
understand
mechan
enhanc
attenu
better
immun
maintain
genet
stabil
cov
lav
candid
critic
vaccin
develop
recombin
cov
mutat
certain
viral
protein
unstabl
vivo
exampl
serial
passag
balbc
mice
day
time
recombin
sarscov
lack
entir
e
protein
acquir
addit
pdzbind
motif
pbm
accessori
protein
compens
loss
motif
e
protein
contrast
catalyt
tetrad
cov
seem
stabl
target
mutagenesi
sarscov
mutant
retain
two
nucleotid
substitut
continu
replic
immunedefici
mice
day
similarli
also
show
nine
nucleotid
substitut
stabl
vivopassag
fig
fecal
sampl
collect
dpi
pig
three
passag
pig
total
day
genom
mutant
acquir
one
addit
amino
acid
substitut
subunit
three
synonym
mutat
fig
howev
unlik
mutat
protein
compens
miss
activ
pedv
mutant
would
interest
evalu
pathogenesi
vivopassag
viru
pig
futur
notabl
compar
young
pig
older
anim
matur
immun
system
induc
stronger
select
pressur
introduc
mutat
also
necessari
evalu
genet
stabil
adult
pig
futur
anoth
approach
prevent
potenti
revers
virul
cov
introduc
mutat
multipl
gene
differ
function
certain
select
pressur
vivo
mutat
one
gene
may
revert
wild
type
addit
mutat
may
still
preserv
retain
attenu
also
two
independ
recombin
event
requir
revert
two
distant
mutat
wild
type
lav
virul
viru
coinfect
cell
one
studi
show
combin
inactiv
reduc
revers
virul
recombin
sarscov
vivo
similar
effect
also
observ
recombin
sarscov
combin
delet
e
protein
studi
combin
mutat
made
endocytosi
signal
interestingli
remov
endocytosi
signal
occur
natur
gene
vero
celladapt
field
pedv
strain
suggest
stabl
pedv
replic
vivo
vitro
collect
data
suggest
engin
mutant
genet
stabl
pig
vaccin
regimen
includ
vaccin
dose
boost
use
adjuv
time
determin
efficaci
pedv
lav
pedvnaiv
pig
neonat
piglet
appropri
target
pedv
vaccin
due
rapid
diseas
develop
death
first
week
life
protect
acquir
pedvneutr
antibodi
via
colostrum
milk
sow
thu
stimul
suffici
lactogen
immun
respons
sow
key
pedv
vaccin
studi
inocul
piglet
pfupig
virul
equival
median
diarrhea
dose
mutant
dose
oral
immun
sow
may
like
need
increas
due
agerel
decreas
suscept
potenti
preexist
pedv
antibodi
older
anim
immunogen
andor
mutant
pregnant
sow
also
need
evalu
futur
recent
studi
demonstr
intramuscular
inocul
virul
pedv
trigger
intestin
infect
pig
suggest
oral
vaccin
may
combin
rout
establish
better
primari
infect
intestin
sow
use
pedv
booster
vaccin
adapt
previou
tgev
rotaviru
studi
administr
subunit
inactiv
vaccin
booster
improv
efficaci
oral
lav
vitamin
probiot
demonstr
effect
adjuv
rotaviru
vaccin
pig
moreov
time
vaccin
significantli
affect
multipl
immun
paramet
sow
recent
studi
show
pedv
infect
second
trimest
gestat
stimul
strongest
protect
immun
respons
gilt
compar
gilt
inocul
first
third
trimest
conclus
develop
evalu
pedv
lav
candid
combin
inactiv
abolish
endocytosi
signal
protein
mutant
pedv
replic
less
effect
induc
stronger
type
type
iii
ifn
respons
cell
cultur
data
illustr
strategi
safe
effect
approach
develop
lav
pedv
well
potenti
swine
enter
cov
vero
cell
atcc
number
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
carlsbad
ca
supplement
fetal
bovin
serum
fb
antibioticsantimycot
gibco
carlsbad
ca
ipecdq
subclon
swine
intestin
epitheli
cell
line
gener
previous
ipecdq
cell
cultur
rpmi
gibco
carlsbad
ca
supplement
fb
propag
pedv
vero
cell
describ
previous
pedv
adsorpt
cell
maintain
dmem
rpmi
supplement
tryptos
phosphat
broth
tpb
sigmaaldrich
st
loui
mo
trypsin
gibco
carlsbad
ca
recombin
human
purchas
pbl
assay
scienc
piscataway
township
nj
sensit
vero
cell
human
pretreat
valid
previou
report
code
sequenc
wildtyp
mutat
clone
vector
describ
previous
wildtyp
luciferas
report
construct
luc
luciferas
report
construct
assay
describ
previous
renilla
luciferas
plasmid
prltk
promega
includ
intern
control
briefli
ipecdq
cell
grown
plate
confluenc
transfect
plasmid
prltk
h
cell
infect
pedv
mutant
moi
cell
lysat
harvest
hpi
luciferas
activ
determin
use
dualluciferas
report
assay
system
promega
madison
wi
signal
obtain
luminomet
wallac
victor
multilabel
counter
perkin
elmer
waltham
structur
pedv
model
swissmodel
http
swissmodelexpasyorg
onlin
tool
use
sarscov
templat
structur
align
sarscov
pedv
perform
use
rcsb
pdb
protein
comparison
tool
http
wwwrcsborg
set
five
plasmid
encod
fulllength
genom
cdna
pedv
strain
genbank
access
gener
previous
point
mutat
introduc
wildtyp
plasmid
use
nebuild
hifi
dna
assembl
master
mix
neb
ipswich
plasmid
verifi
sanger
sequenc
recoveri
recombin
pedv
infecti
cdna
clone
describ
previous
plasmid
digest
purifi
mix
togeth
equal
molar
ratio
fulllength
genom
cdna
ligat
ligas
neb
ipswich
transcrib
rna
use
mmessag
mmachin
transcript
kit
ambion
austin
ca
usa
genom
rna
mix
pedv
n
gene
transcript
electropor
vero
cell
cultur
medium
supplement
trypsin
transfect
cytopath
effect
cpe
appear
within
day
virus
harvest
subject
plaqu
purif
singl
clone
pedv
mutant
propag
vero
cell
gener
viral
stock
fulllength
genom
viru
stock
verifi
sanger
sequenc
addit
recombin
pedv
icya
bear
mutat
genom
gener
previous
includ
studi
control
anim
experi
studi
approv
institut
anim
care
use
committe
iacuc
ohio
state
univers
gn
piglet
deriv
two
pedvnaiv
sow
total
piglet
randomli
divid
four
group
piglet
group
hous
one
isol
describ
previous
day
age
gn
piglet
oral
inocul
recombin
pedv
n
pfupig
n
pfupig
n
pfupig
mock
inocul
n
phosphatebuff
salin
pb
dose
pedv
correspond
strain
cesareanderiv
colostrumdepriv
piglet
titrat
us
previous
two
diarrheic
piglet
group
one
mocktreat
piglet
euthan
dpi
histopatholog
examin
exclud
calcul
mortal
rate
dpi
surviv
pig
challeng
oral
pfu
hous
day
evalu
protect
observ
clinic
sign
includ
diarrhea
vomit
anorexia
rectal
swab
collect
daili
two
addit
time
point
hpi
hour
postchalleng
hpc
sever
diarrhea
score
base
fecal
consist
individu
pig
solid
pasti
semiliquid
mild
diarrhea
liquid
sever
diarrhea
viru
viral
rna
shed
titer
rectal
swab
sampl
determin
plaqu
assay
revers
transcriptionquantit
pcr
rtqpcr
respect
describ
previous
peripher
blood
sampl
collect
dpi
dpi
h
challeng
dpi
day
postchalleng
monitor
serum
antibodi
titer
histopatholog
examin
includ
ihc
stain
pedv
n
antigen
jejunum
ileum
tissu
perform
viral
neutral
antibodi
assay
perform
report
previous
follow
iacuc
protocol
moribund
piglet
show
anorexia
dehydr
h
euthan
base
instruct
institut
veterinarian
enzymelink
immunosorb
assay
elisa
detect
describ
previous
briefli
nunc
maxisorp
plate
coat
antiporcin
mgml
clone
r
system
minneapoli
mn
overnight
biotinyl
antiporcin
mgml
clone
r
system
minneapoli
mn
use
detect
plate
develop
cytokin
concentr
calcul
base
standard
curv
detect
limit
assay
pgml
serial
passag
mutant
gn
pig
smallintestin
content
sic
viru
infect
pig
euthan
dpi
collect
second
pedvnaiv
piglet
day
age
inocul
dilut
sic
contain
pfu
viru
dpi
piglet
euthan
sic
collect
viru
third
pedvnaiv
piglet
day
age
inocul
dilut
sic
contain
pfu
viru
dpi
third
piglet
euthan
sic
collect
total
rna
sic
extract
use
rneasi
minikit
qiagen
germani
total
cdna
gener
revers
transcript
use
super
script
iii
kit
invitrogen
carlsbad
ca
pcr
fragment
cover
complet
pedv
genom
amplifi
use
primestar
hifi
polymeras
takara
japan
confirm
stabil
mutat
recombin
pedv
infect
pig
code
sequenc
cytoplasm
tail
amplifi
rectal
swab
sampl
collect
dpi
revers
transcript
follow
nest
pcr
use
primestar
hifi
polymeras
takara
japan
sanger
sequenc
perform
genom
share
resourc
ohio
state
univers
plaqu
assay
monolay
vero
cell
inocul
serial
dilut
recombin
pedv
h
presenc
trypsin
inocula
remov
vero
cell
wash
twice
pb
cell
overlaid
agaroseminim
essenti
medium
mem
mixtur
supplement
trypsin
tpb
growth
curv
pedv
vero
cell
determin
inocul
monolay
cell
recombin
pedv
moi
h
adsorpt
inocula
remov
cell
monolay
wash
twice
pb
mainten
medium
contain
trypsin
tpb
ad
cell
cultur
total
number
virus
intracellular
extracellular
sampl
determin
freez
thaw
cultur
appropri
time
point
infecti
titer
viral
sampl
determin
plaqu
assay
growth
curv
pedv
ipecdq
cell
moi
determin
similar
procedur
titrat
method
vero
cell
cultur
medium
supplement
differ
concentr
h
prior
pedv
inocul
remov
medium
wash
cell
pb
three
time
cell
inocul
recombin
pedv
moi
cultur
addit
h
supernat
cell
frozen
freez
thaw
sampl
one
pedv
mutant
collect
differ
time
point
titrat
simultan
plaqu
assay
grna
sgmrna
detect
vero
cell
inocul
recombin
pedv
moi
h
total
cellular
rna
isol
use
rneasi
minikit
qiagen
germani
positivesens
viral
rna
revers
transcrib
genespecif
revers
primer
use
moloney
murin
leukemia
viru
mmlv
revers
transcriptas
promega
madison
wi
cdna
subject
quantit
pcr
use
taqman
qpcr
reagent
qiagen
germani
grna
amplifi
forward
primer
tgaagccgtctcatactattctg
revers
primer
aatccctcaacagtgtcagc
probe
fam
tgcaatgccgtttcgtgtccttcblack
hole
quencher
bhq
sgmrnan
amplifi
forward
primer
ctcttgtctactcaattcaactaaacagaaac
revers
primer
ccagtatccaatttgctggtcc
probe
famtcaggatcgtggccgcaaacbhq
amplifi
forward
primer
ctatctacggatagttagctc
revers
primer
ctgtgtcaatcgtgtattg
probe
famacatcactgcacgtggacbgh
copi
number
amplicon
determin
standard
curv
normal
mass
total
cellular
rna
sgmrnan
also
detect
sampl
control
sgmrna
report
copi
per
copi
grna
cellular
ifn
mrna
detect
ipecdq
cell
inocul
recombin
pedv
moi
total
cellular
rna
isol
cellular
dna
remov
treat
rna
dnase
qiagen
one
microgram
total
rna
revers
transcrib
use
mmlv
revers
transcriptas
random
primer
cdna
subject
quantit
pcr
use
sybr
green
pcr
mix
life
technolog
carlsbad
ca
accord
manufactur
instruct
primer
sequenc
describ
previous
gene
use
intern
control
threshold
cycl
ct
valu
target
gene
differ
ct
valu
determin
rel
transcript
level
target
gene
present
fold
chang
rel
respect
control
use
threshold
method
statist
analys
perform
use
graphpad
prism
data
fig
e
shown
boxandwhisk
plot
individu
valu
comparison
mean
group
figur
tabl
fig
e
analyz
oneway
analysi
varianc
anova
follow
tukey
multiplecomparison
test
group
time
point
signific
differ
p
indic
differ
letter
data
fig
f
h
g
analyz
oneway
anova
follow
dunnett
multiplecomparison
test
compar
group
group
time
point
data
fig
f
analyz
student
test
compar
mutant
group
group
data
fig
analyz
log
rank
test
